Takeda Pharmaceutical (OTCMKTS:TKPYY) Sets New 52-Week Low at $13.27

Shares of Takeda Pharmaceutical Company Limited (OTCMKTS:TKPYYGet Rating) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $13.27 and last traded at $13.36, with a volume of 2269333 shares changing hands. The stock had previously closed at $13.12.

The business’s 50 day simple moving average is $14.28 and its 200-day simple moving average is $14.41. The stock has a market capitalization of $20.87 billion, a P/E ratio of 12.11 and a beta of 0.42. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.42 and a quick ratio of 1.12.

About Takeda Pharmaceutical (OTCMKTS:TKPYY)

Takeda Pharmaceutical Co, Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products.

Further Reading

Want More Great Investing Ideas?

Receive News & Ratings for Takeda Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takeda Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.